ESDR 2022 Clinical Saturday
Title: Immune biomarkers for stratified medicine in psoriasis
Date: Saturday 01 October 2022
Dr Di Meglio received her PhD in Pharmacology from the University of Naples Federico II.
She was Visiting Postgraduate Fellow in the Section of Immunobiology at Yale University, Research Associate at St. John’s Institute of Dermatology, and Senior Investigator Scientist at the Francis Crick Institute, formerly MRC National Institute for Medical Research (NIMR) in Mill Hill. In March 2017 she became Lecturer in Cutaneous Immunology at St John’s Institute of Dermatology. Dr Di Meglio’s research interest is in the etiopathogenesis of complex inflammatory skin conditions, with a particular focus on the mechanistic interplay between genetic, environmental and immune factors. She has also an interest in pharmacogenomics and biomarkers discovery. She identified and functionally characterized the IL23R R381Q gene variant conferring protection to psoriasis and other inflammatory diseases. Her more recent work has uncovered the beneficial role of the transcription factor and environmental sensor AhR in skin inflammation. Dr Di Meglio has been the recipient of the European Society for Dermatological Research (EASDR)/Celgene Award, and of the British Society for Investigative Dermatology (BSID) Young Investigator Award, both in 2014. She is Section Editor in Dermatology and Skin Immunology for Pharmacological Research.
Dr Di Meglio has given over 30 invited lectures, including at the World Congress of Dermatology in 2015 and at the Montagna Symposium on the Biology of Skin in 2017.
More information on the website: www.kcl.ac.uk/people/paola-di-meglio